Back to search
FDAFDA · Food and drugs·Recall number D-0868-2026

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1

Published September 30, 2026 · Recall initiated: August 28, 2026

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: Possibility of no medication in the prefilled pen.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
EXENATIDE
Manufacturer
Amneal Pharmaceuticals of New York, LLC
Distributor
USA Nationwide
Lot
Lot #: AP250095A, Exp 2/28/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1 recalled?

Yes. FDA published recall D-0868-2026 on September 30, 2026. Reported hazard: Defective Delivery System: Possibility of no medication in the prefilled pen.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: EXENATIDE.

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Recalert also tracks expiration dates so you can sell stock before it becomes a loss.

Check your inventory (free)